Prime Medicine, Inc. (PRME)
USD 2.64
(-9.28%)
USD 2.64
(-9.28%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | - | - | - | 5.21 Million | - |
| Cost of Revenue | 147.9 Million | - | - | - | 2.76 Million |
| Gross Profit | -147.9 Million | - | - | - | -2.76 Million |
| Operating Expenses | 186.63 Million | 116.54 Million | 84.47 Million | 6.14 Million | 2.17 Million |
| Selling, General and Administrative Expenses | 38.73 Million | 29.81 Million | 13.92 Million | 3.16 Million | 1.25 Million |
| Research and Development Expenses | 147.9 Million | 86.72 Million | 70.55 Million | 2.98 Million | 920 Thousand |
| Other Expenses | - | 1.9 Million | -80.98 Million | -11.47 Million | - |
| Cost and Expenses | 191.29 Million | 116.54 Million | 84.47 Million | 6.14 Million | 2.17 Million |
| Operating Income | -191.29 Million | -116.54 Million | -84.47 Million | -932 Thousand | -2.17 Million |
| Interest Expense | - | 12.12 Million | - | - | - |
| Income Tax Expense | -279 Thousand | -948 Thousand | -486 Thousand | 1.86 Million | 4000.00 |
| Earnings before Tax | -198.41 Million | -122.76 Million | -165.85 Million | -1.54 Million | -2.52 Million |
| Net Income | -198.13 Million | -121.82 Million | -165.36 Million | -3.41 Million | -2.52 Million |
| Earnings Per Share Basic | -2.18 | -1.25 | -2.55 | -0.07 | -0.03 |
| Earnings Per Share Diluted | -2.18 | -1.25 | -2.55 | -0.07 | -0.03 |
| Weighted Average Shares Outstanding | 90.96 Million | 97.2 Million | 64.9 Million | 71.79 Million | 95.73 Million |
| Weighted Average Shares Outstanding (Diluted) | 90.96 Million | 97.2 Million | 64.9 Million | 71.79 Million | 95.73 Million |
| Gross Margin | - | -1.31 | - | - | - |
| EBIT Margin | - | -20.81 | - | -2.26 | - |
| Profit Margin | - | -23.38 | - | -0.65 | - |
| EBITDA | -193.75 Million | -110.75 Million | -160.99 Million | -889 Thousand | -2.17 Million |
| Earnings Before Tax Margin | - | -22.37 | - | -0.18 | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 39.31 Million | 591 Thousand | - | - | - | - |
| Cost of Revenue | 1.53 Million | - | - | - | - | - |
| Gross Profit | 37.77 Million | - | - | - | - | - |
| Operating Expenses | 55.67 Million | 48.93 Million | 186.63 Million | 54.54 Million | 51.45 Million | 45.25 Million |
| Selling, General and Administrative Expenses | 12.6 Million | 11.15 Million | - | 13.08 Million | 10.49 Million | 10.65 Million |
| Research and Development Expenses | 43.07 Million | 37.77 Million | - | 41.45 Million | 40.96 Million | 34.59 Million |
| Other Expenses | 39 Thousand | 1.54 Million | 13.5 Million | 1.76 Million | 2.22 Million | 2.64 Million |
| Cost and Expenses | 55.67 Million | 48.93 Million | 191.29 Million | 54.54 Million | 51.45 Million | 45.25 Million |
| Operating Income | -55.67 Million | -48.34 Million | -191.29 Million | -68.04 Million | -51.45 Million | -45.25 Million |
| Interest Expense | - | - | - | - | - | - |
| Income Tax Expense | -134 Thousand | 134 Thousand | -279 Thousand | 558 Thousand | -108 Thousand | 31 Thousand |
| Earnings before Tax | -55.46 Million | -45.62 Million | -198.41 Million | -65.64 Million | -50.81 Million | -42.35 Million |
| Net Income | -55.32 Million | -45.76 Million | -198.13 Million | -65.64 Million | -50.7 Million | -42.38 Million |
| Earnings Per Share Basic | -0.46 | -0.44 | - | -0.67 | -0.55 | -0.47 |
| Earnings Per Share Diluted | -0.46 | -0.44 | - | -0.67 | -0.55 | -0.47 |
| Weighted Average Shares Outstanding | 119.18 Million | 104.46 Million | 90.96 Million | 97.37 Million | 91.84 Million | 90.46 Million |
| Weighted Average Shares Outstanding (Diluted) | 119.18 Million | 104.46 Million | 90.96 Million | 97.37 Million | 91.84 Million | 90.46 Million |
| Gross Margin | 0.96 | - | - | - | - | - |
| EBIT Margin | -1.33 | -81.54 | - | - | - | - |
| Profit Margin | -1.41 | -77.43 | - | -2.55 | - | - |
| EBITDA | -52.2 Million | -48.19 Million | - | -40.43 Million | -48.64 Million | -44.4 Million |
| Earnings Before Tax Margin | -1.42 | -81.80 | - | - | - | - |
1530
DNR
123700
TIL
SIHBY
OCUP